![](/img/cover-not-exists.png)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
Miles, D. W., Chan, A., Dirix, L. Y., Cortes, J., Pivot, X., Tomczak, P., Delozier, T., Sohn, J. H., Provencher, L., Puglisi, F., Harbeck, N., Steger, G. G., Schneeweiss, A., Wardley, A. M., ChlistallVolume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2008.21.6457
Date:
July, 2010
File:
PDF, 266 KB
english, 2010